Point72 Asset Management
AXSM icon

Point72 Asset Management’s Axsome Therapeutics AXSM Stock Holding History

Point72 Asset Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,400
Closed -$804K – 3780
2025
Q4 		$804K Hold
4,400
– – ﹤0.01% 2993
2025
Q3 		$534K Hold
4,400
– – ﹤0.01% 1898
2025
Q2 		$459K Sell
4,400
-200
-4% -$21.2K ﹤0.01% 1814
2025
Q1 		$536K Buy
+4,600
New +$524K ﹤0.01% 1615
2024
Q4 		– Sell
-10,900
Closed -$980K – 2079
2024
Q3 		$980K Hold
10,900
– – ﹤0.01% 1424
2024
Q2 		$877K Buy
10,900
+2,500
+30% +$185K ﹤0.01% 1304
2024
Q1 		$670K Buy
+8,400
New +$705K ﹤0.01% 1564

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return